Record Information
Version1.0
Creation Date2013-04-25 07:56:51 UTC
Update Date2026-03-25 19:26:18 UTC
Accession NumberCHEM002798
Identification
Common NameFenamiphos
ClassSmall Molecule
DescriptionFenamiphos is an organophosphate acetylcholinesterase inhibitor insecticide (nematicide) used to control a wide variety of nematode (round worm) pests. Nematodes can live as parasites on or within a plant. They may be free living or associated with cyst and root-knot formations in plants. Fenamiphos is used on a variety of plants including tobacco, cocoa, turf, bananas, pineapples, citrus and other fruit vines, and on some vegetables and grains. The compound is absorbed by the roots and is then transported throughout the plant. Fenamiphos, similar to other organophosphates, blocks the enzyme acetyl cholinesterase in the target pest. The enzyme regulates inter-cellular activity. The pesticide is also active against non-target invertebrates such as sucking insects and spider mites.
Contaminant Sources
  • Clean Air Act Chemicals
  • FooDB Chemicals
  • HPV EPA Chemicals
  • My Exposome Chemicals
  • STOFF IDENT Compounds
  • T3DB toxins
  • ToxCast & Tox21 Chemicals
Contaminant Type
  • Ester
  • Ether
  • Food Toxin
  • Insecticide
  • Metabolite
  • Organic Compound
  • Pesticide
  • Synthetic Compound
Chemical Structure
Thumb
Synonyms
ValueSource
Ethyl 3-methyl-4-(methylsulfanyl)phenyl (1-methylethyl)amidophosphateChEBI
Ethyl 3-methyl-4-(methylthio)phenyl isopropylphosphoramidateChEBI
Ethyl 4-(methylthio)-m-tolyl isopropylphosphoramidateChEBI
Isopropylamino-O-ethyl-(4-methylmercapto-3-methylphenyl)phosphateChEBI
MethaphenamiphosChEBI
NemacurChEBI
PhenamiphosChEBI
Ethyl 3-methyl-4-(methylsulfanyl)phenyl (1-methylethyl)amidophosphoric acidGenerator
Ethyl 3-methyl-4-(methylsulphanyl)phenyl (1-methylethyl)amidophosphateGenerator
Ethyl 3-methyl-4-(methylsulphanyl)phenyl (1-methylethyl)amidophosphoric acidGenerator
Ethyl 3-methyl-4-(methylthio)phenyl isopropylphosphoramidic acidGenerator
Ethyl 4-(methylthio)-m-tolyl isopropylphosphoramidic acidGenerator
Isopropylamino-O-ethyl-(4-methylmercapto-3-methylphenyl)phosphoric acidGenerator
BAY sra 3886HMDB
Ethyl 3-methyl-4-(methylthio)phenyl 1-methylethylphosphoramidate, 9ciHMDB
Ethyl 3-methyl-4-(methylthio)phenyl isopropylamidophosphateHMDB
Ethyl 4-(methylthio)m-tolyl isopropylphosphoroamidateHMDB
Ethyl 4-methylthio-m-tolyl isopropylphosphoramidate, 8ciHMDB
Ethyl-4-(methylthio)-m-tolyl isopropylphosphoramidateHMDB
m-Cresol, 4-(methylthio)-, ethyl isopropylphosphoramidateHMDB
Nemacur pHMDB
Phenamifos sulfoxideHMDB
Chemical FormulaC13H22NO3PS
Average Molecular Mass303.357 g/mol
Monoisotopic Mass303.106 g/mol
CAS Registry Number22224-92-6
IUPAC Name{ethoxy[3-methyl-4-(methylsulfanyl)phenoxy]phosphoryl}(propan-2-yl)amine
Traditional Namefenamiphos
SMILESCCOP(=O)(NC(C)C)OC1=CC=C(SC)C(C)=C1
InChI IdentifierInChI=1S/C13H22NO3PS/c1-6-16-18(15,14-10(2)3)17-12-7-8-13(19-5)11(4)9-12/h7-10H,6H2,1-5H3,(H,14,15)
InChI KeyZCJPOPBZHLUFHF-UHFFFAOYSA-N
Chemical Taxonomy
Description belongs to the class of organic compounds known as phenoxy compounds. These are aromatic compounds contaning a phenoxy group.
KingdomOrganic compounds
Super ClassBenzenoids
ClassBenzene and substituted derivatives
Sub ClassPhenoxy compounds
Direct ParentPhenoxy compounds
Alternative Parents
Substituents
  • Phenoxy compound
  • Aryl thioether
  • Thiophenol ether
  • Phosphoric diester monoamide
  • Toluene
  • Alkylarylthioether
  • Organic phosphoric acid derivative
  • Phosphoric acid ester
  • Organic phosphoric acid amide
  • Sulfenyl compound
  • Thioether
  • Organopnictogen compound
  • Organic oxygen compound
  • Organic nitrogen compound
  • Organosulfur compound
  • Organooxygen compound
  • Organic oxide
  • Organonitrogen compound
  • Hydrocarbon derivative
  • Aromatic homomonocyclic compound
Molecular FrameworkAromatic homomonocyclic compounds
External Descriptors
Biological Properties
StatusDetected and Not Quantified
OriginExogenous
Cellular Locations
  • Membrane
Biofluid LocationsNot Available
Tissue LocationsNot Available
PathwaysNot Available
Applications
Biological Roles
Chemical Roles
Physical Properties
StateSolid
AppearanceWhite powder.
Experimental Properties
PropertyValue
Melting Point49°C
Boiling PointNot Available
Solubility0.329 mg/mL at 20°C
Predicted Properties
PropertyValueSource
Water Solubility0.32 g/LALOGPS
logP3.05ALOGPS
logP3.31ChemAxon
logS-3ALOGPS
pKa (Strongest Acidic)10.54ChemAxon
Physiological Charge0ChemAxon
Hydrogen Acceptor Count1ChemAxon
Hydrogen Donor Count1ChemAxon
Polar Surface Area47.56 ŲChemAxon
Rotatable Bond Count7ChemAxon
Refractivity81.54 m³·mol⁻¹ChemAxon
Polarizability31.97 ųChemAxon
Number of Rings1ChemAxon
Bioavailability1ChemAxon
Rule of FiveYesChemAxon
Ghose FilterYesChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleNoChemAxon
Spectra
Spectra
Spectrum TypeDescriptionSplash KeyView
Predicted GC-MSPredicted GC-MS Spectrum - GC-MS (Non-derivatized) - 70eV, Positivesplash10-0w99-3890000000-69a80218e9aa4efa6a6eSpectrum
Predicted GC-MSPredicted GC-MS Spectrum - GC-MS (Non-derivatized) - 70eV, PositiveNot AvailableSpectrum
LC-MS/MSLC-MS/MS Spectrum - 60V, Positivesplash10-0uxr-0390000000-27a48287856f24d6700cSpectrum
LC-MS/MSLC-MS/MS Spectrum - 75V, Positivesplash10-0udi-2690000000-b722d2a9468435e12094Spectrum
LC-MS/MSLC-MS/MS Spectrum - 30V, Positivesplash10-0159-0090000000-d4a04a50c394cba968e1Spectrum
LC-MS/MSLC-MS/MS Spectrum - 45V, Positivesplash10-014i-0090000000-93cb423c35280cf6e7a7Spectrum
LC-MS/MSLC-MS/MS Spectrum - 15V, Positivesplash10-0udi-0069000000-96078b842ad6c61e3d2aSpectrum
LC-MS/MSLC-MS/MS Spectrum - 90V, Positivesplash10-0udi-5940000000-d70a968d944ba49dd1ceSpectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 10V, Positivesplash10-002r-1961000000-6a59a7d3929cb6c1f452Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 20V, Positivesplash10-001i-1390000000-87f8471e9c820add2e93Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 40V, Positivesplash10-000i-4900000000-26f0133ccf950f4cf465Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 10V, Negativesplash10-0zfs-4293000000-8d0f5c9a48d2dd05e238Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 20V, Negativesplash10-004i-2290000000-1a517cae8a7e665e46e0Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 40V, Negativesplash10-000b-7910000000-0b3532563157c053e6b1Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 10V, Negativesplash10-0udi-0129000000-c0cdb30129c325b775b6Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 20V, Negativesplash10-0udi-0901000000-5cbc3028107c94f320c3Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 40V, Negativesplash10-0udi-0910000000-6fc9bd5a7c66c0afa14bSpectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 10V, Positivesplash10-0imi-0193000000-f9f9fe0b8a64c4666f70Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 20V, Positivesplash10-00or-0390000000-41b52eaec89c60dbd994Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 40V, Positivesplash10-052u-6930000000-918bc9e7576314e226bbSpectrum
MSMass Spectrum (Electron Ionization)splash10-0udi-8953000000-a605d591b58cd6b9edb9Spectrum
Toxicity Profile
Route of ExposureNot Available
Mechanism of ToxicityFenamiphos is a cholinesterase or acetylcholinesterase (AChE) inhibitor. A cholinesterase inhibitor (or 'anticholinesterase') suppresses the action of acetylcholinesterase. Because of its essential function, chemicals that interfere with the action of acetylcholinesterase are potent neurotoxins, causing excessive salivation and eye-watering in low doses, followed by muscle spasms and ultimately death. Nerve gases and many substances used in insecticides have been shown to act by binding a serine in the active site of acetylcholine esterase, inhibiting the enzyme completely. Acetylcholine esterase breaks down the neurotransmitter acetylcholine, which is released at nerve and muscle junctions, in order to allow the muscle or organ to relax. The result of acetylcholine esterase inhibition is that acetylcholine builds up and continues to act so that any nerve impulses are continually transmitted and muscle contractions do not stop. Among the most common acetylcholinesterase inhibitors are phosphorus-based compounds, which are designed to bind to the active site of the enzyme. The structural requirements are a phosphorus atom bearing two lipophilic groups, a leaving group (such as a halide or thiocyanate), and a terminal oxygen.
MetabolismMetabolism of organophosphates occurs principally by oxidation, by hydrolysis via esterases and by reaction with glutathione. Demethylation and glucuronidation may also occur. Oxidation of organophosphorus pesticides may result in moderately toxic products. In general, phosphorothioates are not directly toxic but require oxidative metabolism to the proximal toxin. The glutathione transferase reactions produce products that are, in most cases, of low toxicity. Paraoxonase (PON1) is a key enzyme in the metabolism of organophosphates. PON1 can inactivate some organophosphates through hydrolysis. PON1 hydrolyzes the active metabolites in several organophosphates insecticides as well as, nerve agents such as soman, sarin, and VX. The presence of PON1 polymorphisms causes there to be different enzyme levels and catalytic efficiency of this esterase, which in turn suggests that different individuals may be more susceptible to the toxic effect of organophosphate exposure.
Toxicity ValuesNot Available
Lethal DoseNot Available
Carcinogenicity (IARC Classification)No indication of carcinogenicity to humans (not listed by IARC).
Uses/SourcesThis is a man-made compound that is used as a pesticide.
Minimum Risk LevelNot Available
Health EffectsAcute exposure to cholinesterase inhibitors can cause a cholinergic crisis characterized by severe nausea/vomiting, salivation, sweating, bradycardia, hypotension, collapse, and convulsions. Increasing muscle weakness is a possibility and may result in death if respiratory muscles are involved. Accumulation of ACh at motor nerves causes overstimulation of nicotinic expression at the neuromuscular junction. When this occurs symptoms such as muscle weakness, fatigue, muscle cramps, fasciculation, and paralysis can be seen. When there is an accumulation of ACh at autonomic ganglia this causes overstimulation of nicotinic expression in the sympathetic system. Symptoms associated with this are hypertension, and hypoglycemia. Overstimulation of nicotinic acetylcholine receptors in the central nervous system, due to accumulation of ACh, results in anxiety, headache, convulsions, ataxia, depression of respiration and circulation, tremor, general weakness, and potentially coma. When there is expression of muscarinic overstimulation due to excess acetylcholine at muscarinic acetylcholine receptors symptoms of visual disturbances, tightness in chest, wheezing due to bronchoconstriction, increased bronchial secretions, increased salivation, lacrimation, sweating, peristalsis, and urination can occur. Certain reproductive effects in fertility, growth, and development for males and females have been linked specifically to organophosphate pesticide exposure. Most of the research on reproductive effects has been conducted on farmers working with pesticides and insecticdes in rural areas. In females menstrual cycle disturbances, longer pregnancies, spontaneous abortions, stillbirths, and some developmental effects in offspring have been linked to organophosphate pesticide exposure. Prenatal exposure has been linked to impaired fetal growth and development. Neurotoxic effects have also been linked to poisoning with OP pesticides causing four neurotoxic effects in humans: cholinergic syndrome, intermediate syndrome, organophosphate-induced delayed polyneuropathy (OPIDP), and chronic organophosphate-induced neuropsychiatric disorder (COPIND). These syndromes result after acute and chronic exposure to OP pesticides.
SymptomsSymptoms of low dose exposure include excessive salivation and eye-watering. Acute dose symptoms include severe nausea/vomiting, salivation, sweating, bradycardia, hypotension, collapse, and convulsions. Increasing muscle weakness is a possibility and may result in death if respiratory muscles are involved. Hypertension, hypoglycemia, anxiety, headache, tremor and ataxia may also result.
TreatmentIf the compound has been ingested, rapid gastric lavage should be performed using 5% sodium bicarbonate. For skin contact, the skin should be washed with soap and water. If the compound has entered the eyes, they should be washed with large quantities of isotonic saline or water. In serious cases, atropine and/or pralidoxime should be administered. Anti-cholinergic drugs work to counteract the effects of excess acetylcholine and reactivate AChE. Atropine can be used as an antidote in conjunction with pralidoxime or other pyridinium oximes (such as trimedoxime or obidoxime), though the use of '-oximes' has been found to be of no benefit, or possibly harmful, in at least two meta-analyses. Atropine is a muscarinic antagonist, and thus blocks the action of acetylcholine peripherally.
Concentrations
Not Available
DrugBank IDNot Available
HMDB IDHMDB0031787
FooDB IDFDB008460
Phenol Explorer IDNot Available
KNApSAcK IDNot Available
BiGG IDNot Available
BioCyc IDNot Available
METLIN IDNot Available
PDB IDNot Available
Wikipedia LinkFenamiphos
Chemspider ID28827
ChEBI ID38680
PubChem Compound ID31070
Kegg Compound IDC18659
YMDB IDNot Available
ECMDB IDNot Available
References
Synthesis ReferenceNot Available
MSDSNot Available
General References
1. Yannai, Shmuel. (2004) Dictionary of food compounds with CD-ROM: Additives, flavors, and ingredients. Boca Raton: Chapman & Hall/CRC.